XML 71 R44.htm IDEA: XBRL DOCUMENT v3.25.4
Supplemental Financial Information (Tables)
 12 Months Ended
Dec. 31, 2025
Supplemental Balance Sheet Information [Abstract]  
Schedule of Cash and Cash Equivalents
The reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheet to the totals shown within the consolidated statements of cash flows is as follows (in thousands):
As of December 31,
202520242023
Cash and cash equivalents$167,202 $561,572 $944,073 
Restricted cash included in prepaid expenses and other current assets (1)
7,031 5,839 4,789 
Restricted cash included in other non-current assets (1)
38,138 38,332 40,722 
Total cash, cash equivalents and restricted cash$212,371 $605,743 $989,584 
(1)Includes cash balances collateralizing letters of credit associated with the Company’s facility leases and customer prepayments requiring segregation and restrictions in its use in accordance with the customer agreement.
Restrictions on Cash and Cash Equivalents
The reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheet to the totals shown within the consolidated statements of cash flows is as follows (in thousands):
As of December 31,
202520242023
Cash and cash equivalents$167,202 $561,572 $944,073 
Restricted cash included in prepaid expenses and other current assets (1)
7,031 5,839 4,789 
Restricted cash included in other non-current assets (1)
38,138 38,332 40,722 
Total cash, cash equivalents and restricted cash$212,371 $605,743 $989,584 
(1)Includes cash balances collateralizing letters of credit associated with the Company’s facility leases and customer prepayments requiring segregation and restrictions in its use in accordance with the customer agreement.
Schedule of Property, Plant and Equipment Net Estimated lives of property, plant and equipment are as follows:
Estimated Useful Life
Computer equipment and software
2 to 5 years
Furniture and fixtures7 years
Lab equipment
1 to 5 years
Buildings and facilities
15 to 30 years
Vehicles5 years
Leasehold improvementsShorter of useful life or remaining lease term
Property, plant and equipment, net consisted of the following (in thousands):
As of December 31,
20252024
Lab equipment$146,279 $150,887 
Leasehold improvements140,513 135,964 
Buildings and facilities49,760 48,255 
Construction in progress192 1,984 
Computer equipment and software9,056 14,897 
Furniture and fixtures6,520 6,545 
Land6,060 6,060 
Total property, plant, and equipment358,380 364,592 
Less: Accumulated depreciation(190,597)(160,872)
Property, plant and equipment, net$167,783 $203,720 
Schedule of Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following (in thousands):
As of December 31,
20252024
Operating lease liabilities$22,787 $28,630 
Contractual shortfall liabilities (Note 12)15,919 — 
Contingent consideration liability5,438 5,438 
Biosecurity costs5,046 4,032 
Employee compensation and benefits4,258 9,894 
Professional fees and securities litigation costs4,378 2,167 
External research and development expenses1,072 713 
Deferred other income1,033 2,889 
Employee termination costs816 2,387 
Finance lease liabilities20 335 
Property and equipment— 138 
Other current liabilities5,691 8,764 
Accrued expenses and other current liabilities$66,458 $65,387 
Schedule of Operating Leases Supplemental Cash Flow Information
Supplemental cash flow information related to the Company’s operating leases were as follows (in thousands):
Year Ended December 31,
202520242023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$61,178 $45,019 $44,051 
Operating cash flows from finance leases4 32 83 
Financing cash flows from finance leases354 897 1,295 
The following table presents supplemental cash flow information for each reporting period (in thousands):
Year Ended December 31,
202520242023
Cash paid for interest$4 $32 $83 
Cash paid for income taxes192 894 670 
Non-cash investing and financing activities:
ROU assets obtained in exchange for new operating lease liabilities336 223,853 27,668 
Purchases of property and equipment included in accounts payable and accrued expenses46 2,565 2,915 
Convertible financial instruments received for Cell Engineering services— — 4,542 
Equity securities and warrants received for Cell Engineering services— 55 17,450 
Common stock issued for acquisitions777 18,245 6,820 
Common stock issued as settlement of contingent consideration liabilities— 14,742 8,896 
Common stock issued for retention payments related to business and asset acquisitions— 5,258 — 
Return of investment in equity securities for reduction in deferred revenue— 6,760 — 
Conversion of notes receivable for common stock— 10,476 — 
Issuance costs related to ATM offering included in accounts payable and accrued expenses53 — — 
For the years ended December 31, 2025, the amount of cash income taxes paid by the Company was as follows (in thousands):

Year Ended December 31,
2025
Federal$— 
State and local:
California12 
South Carolina148 
All other state and local32 
Foreign— 
Cash income taxes, net of refunds$192